ISO 10993 Biocompatibility Testing for Wearables: Full Cost & Timeline Breakdown
If your device touches skin for more than 30 days, ISO 10993 is not optional. It is the regulatory expectation on every continent. Yet for many wearable brands entering the medical market, biocompatibility is the requirement they learn about last — often during a submission review, when the notified body asks for a biological evaluation report that does not exist.
This article covers what ISO 10993 testing actually requires for wearable devices, how to determine which tests apply to your product, the real cost of each test, the timeline from sample submission to final report, and how chemical characterization under ISO 10993-18 can reduce — but not eliminate — the need for animal testing.
Why “Skin Contact” Triggers a Regulatory Obligation
The ISO 10993 series applies to any medical device that has direct or indirect contact with the patient. For wearable devices, the relevant contact classification is surface device, intact skin, limited contact (≤ 24 hours), prolonged contact (24 hours to 30 days), or permanent contact (> 30 days).
A smartwatch worn 24/7 is a permanent-contact surface device. A smart ring worn during sleep tracking is a prolonged-contact device. An ECG patch worn for 72 hours is a prolonged-contact device. All three require biological evaluation.
The regulatory trigger is not whether the device is “invasive” — it is whether the device contacts the patient. Skin is the largest organ in the human body, and prolonged contact with a material that leaches irritants, sensitizers, or cytotoxic compounds can cause harm that manifests weeks or months after first use.
The ISO 10993 Standard Family: A Map
ISO 10993 is not a single standard. It is a family of over 20 parts, each addressing a different aspect of biological evaluation. For wearable devices, the following parts are most relevant:
| Part | Title | Relevance to Wearables |
|---|---|---|
| ISO 10993-1 | Evaluation and testing within a risk management process | Required. Provides the framework for determining which tests are needed based on contact type and duration. |
| ISO 10993-5 | Tests for in vitro cytotoxicity | Required for all skin-contact devices. Tests whether material extracts kill or inhibit cell growth. |
| ISO 10993-10 | Tests for skin sensitization and irritation | Required for prolonged/permanent contact. Evaluates allergic reaction and local irritation potential. |
| ISO 10993-23 | Tests for irritation (in vitro) | Alternative to animal-based irritation testing. Increasingly preferred by regulators. |
| ISO 10993-18 | Chemical characterization of materials | Strongly recommended. Identifies leachable chemicals and can reduce the biological testing burden. |
| ISO 10993-17 | Toxicological risk assessment of leachables | Required if chemical characterization identifies leachables above the analytical evaluation threshold. |
Determining Your Test Matrix: Contact Type × Duration
ISO 10993-1 provides an endpoint matrix that maps contact type and duration to required biological endpoints. For a wearable device with intact skin contact, the matrix yields:
| Endpoint | Limited (≤ 24h) | Prolonged (24h-30d) | Permanent (> 30d) |
|---|---|---|---|
| Cytotoxicity | Required | Required | Required |
| Sensitization | Case-by-case | Required | Required |
| Irritation / Intracutaneous reactivity | Case-by-case | Required | Required |
| Acute systemic toxicity | Case-by-case | Case-by-case | Case-by-case |
| Subchronic toxicity | Not required | Not required | Case-by-case |
| Genotoxicity | Not required | Not required | Case-by-case |
| Implantation | Not required | Not required | Not required |
For a typical smartwatch or smart ring with permanent skin contact, the minimum test package is: cytotoxicity + sensitization + irritation. Additional endpoints are evaluated on a case-by-case basis depending on the materials, manufacturing process, and chemical characterization results.
Cost Breakdown: What Each Test Actually Costs
The following costs are based on 2026 pricing from GLP-accredited laboratories in the US, EU, and China. Prices vary by lab, sample preparation complexity, and whether the test is performed under GLP (required for regulatory submissions).
| Test | Standard | Cost Range (USD) | Duration | GLP Required? |
|---|---|---|---|---|
| In vitro cytotoxicity (MEM elution) | ISO 10993-5 | $800-$1,500 | 2-3 weeks | Yes |
| Skin sensitization (LLNA or GPMT) | ISO 10993-10 | $3,000-$6,000 | 6-8 weeks | Yes |
| Irritation (intracutaneous) | ISO 10993-10 | $2,000-$4,000 | 4-6 weeks | Yes |
| Irritation (in vitro reconstructed epidermis) | ISO 10993-23 | $1,500-$2,500 | 3-4 weeks | Yes |
| Chemical characterization (GC-MS + LC-MS) | ISO 10993-18 | $5,000-$12,000 | 6-10 weeks | No (but GLP strongly recommended) |
| Toxicological risk assessment | ISO 10993-17 | $3,000-$8,000 | 3-4 weeks | N/A (desk-based) |
| Genotoxicity (Ames + micronucleus) | ISO 10993-3 | $4,000-$8,000 | 6-8 weeks | Yes |
Total for a typical wearable baseline package (cytotoxicity + sensitization + irritation): $5,800-$11,500, 8-12 weeks.
Total with chemical characterization and toxicological assessment: $13,800-$31,500, 14-20 weeks. The wide range reflects the difference between a simple device with known materials and a complex device with multiple material families, coatings, adhesives, and colorants.
Chemical Characterization: The Smartest Money You Can Spend
ISO 10993-18 chemical characterization is not a biological test. It is an analytical chemistry exercise: extract the device in solvents that simulate the body environment, then analyze the extract using gas chromatography-mass spectrometry (GC-MS) and liquid chromatography-mass spectrometry (LC-MS) to identify and quantify every chemical that leaches out.
Why invest in chemical characterization when it is technically optional? Three reasons:
- It can reduce the biological testing burden. If chemical characterization demonstrates that no leachables exceed the analytical evaluation threshold (AET), and toxicological risk assessment (ISO 10993-17) confirms that identified leachables are below toxicologically relevant thresholds, some biological endpoints can be waived. This is explicitly allowed under ISO 10993-1 and is increasingly accepted by FDA and EU notified bodies.
- It identifies problems before biological testing. A cytotoxicity test costs $800-$1,500 and takes 2-3 weeks. If it fails, you need to identify the problematic material, reformulate, and retest. Chemical characterization can identify problematic extractables before the biological test cycle begins, saving both time and money.
- It is becoming the regulatory expectation. EU MDR requires a biological evaluation plan and report as part of the technical documentation. Chemical characterization is the preferred method for demonstrating that the biological evaluation is based on a thorough understanding of the device’s material composition. Submissions without chemical characterization face more scrutiny and more requests for additional information.
FDA vs EU MDR: Key Differences in Biocompatibility Expectations
| Aspect | FDA | EU MDR |
|---|---|---|
| Guidance document | FDA Guidance on ISO 10993-1 (2023) | MDR Annex I, GSPR 10; EN ISO 10993 series |
| Chemical characterization | Strongly recommended for all devices; required for devices with novel materials | Effectively required — the biological evaluation must address material composition comprehensively |
| In vitro irritation (ISO 10993-23) | Accepted as alternative to animal testing | Preferred over animal testing per MDR emphasis on reducing animal studies |
| Biological Evaluation Plan (BEP) | Expected but not explicitly required in guidance | Required as part of technical documentation |
| Biological Evaluation Report (BER) | Required in 510(k) or PMA submission | Required as part of technical documentation |
| Material changes | Require re-evaluation; documented in change control | Require re-evaluation as part of post-market surveillance and change notification |
Common Failure Modes and What They Cost to Fix
Nickel release from stainless steel components
Stainless steel is not inherently nickel-free. Even 316L surgical stainless steel contains 10-14% nickel, and under prolonged skin contact with sweat, nickel can leach. The sensitization test detects this, and a positive result requires either switching to a nickel-free alloy (titanium, 904L stainless steel) or applying a barrier coating — both of which involve tooling changes and re-validation.
Cost to fix: $5,000-$15,000 in material and tooling changes, plus 8-12 weeks re-testing.
Silicone curing agent residues
Silicone watch bands and seals are manufactured with peroxide or platinum catalysts. Incomplete curing leaves residual curing agents that can be cytotoxic or sensitizing. A post-cure process (additional heat treatment after molding) resolves most cases, but if the base silicone formulation is incompatible with skin contact, the entire material must be re-sourced.
Cost to fix: Post-cure process validation: $2,000-$5,000. Material re-sourcing: $10,000-$30,000 plus tooling changes.
Adhesive and coating leachables
The adhesives used to bond display modules, seal enclosures, and attach sensors are a common source of unexpected leachables. Many industrial adhesives are not formulated for prolonged skin contact. Chemical characterization often identifies adhesive leachables that were not disclosed on the material datasheet because the manufacturer never intended the adhesive for medical use.
Cost to fix: Adhesive substitution: $3,000-$8,000 in process re-validation. Worst case: re-design of the bonding method: $15,000-$40,000.
Material Selection: Three Categories, Three Pathways
Housing and enclosure materials
Typical materials: stainless steel, titanium, aluminum, polycarbonate, ABS, nylon. The key variable is metal ion release (nickel, chromium, cobalt). For metal housings, request the material’s composition certificate and verify that it meets the nickel release limits in EN 1811 if marketed in the EU. For plastic housings, request the resin supplier’s ISO 10993 test data — many medical-grade resins are pre-tested, which can reduce your testing scope.
Band and strap materials
Typical materials: silicone, TPU, fluoroelastomer, woven nylon, leather. Silicone and TPU are the most common for medical wearables because they are inert, cleanable, and available in medical-grade formulations. The key risk is plasticizer and curing agent leaching. Always specify medical-grade silicone (e.g., USP Class VI or ISO 10993 tested) rather than industrial-grade — the cost difference is approximately $0.50-$1.50 per band, and the testing cost avoidance is 10-50x that.
Sensor electrode materials
Typical materials: stainless steel, conductive silicone, silver/silver chloride (Ag/AgCl). Electrodes present the highest biocompatibility risk because they are in direct, prolonged electrical contact with skin. Ag/AgCl electrodes require particular attention — silver is a known sensitizer, and the chloride component can cause local irritation. Electrode materials should be the first item submitted for biocompatibility testing, not the last.
Frequently Asked Questions
Do smartwatches and fitness trackers need ISO 10993 biocompatibility testing?
If marketed as general wellness products with no medical claims, ISO 10993 testing is not strictly required — but it is strongly recommended for any device worn continuously on skin. If the device makes any medical claim (heart rate monitoring for clinical use, SpO₂ for health assessment, ECG for arrhythmia detection), ISO 10993 evaluation is required by both FDA and EU MDR. The safest approach is to conduct at minimum cytotoxicity and irritation testing for any device with prolonged skin contact.
How much does ISO 10993 biocompatibility testing cost?
A baseline package of cytotoxicity, sensitization, and irritation testing costs $5,800-$11,500 and takes 8-12 weeks. Adding chemical characterization (ISO 10993-18) and toxicological risk assessment (ISO 10993-17) brings the total to $13,800-$31,500 over 14-20 weeks. The wide range reflects differences in device complexity, number of materials, and whether pre-existing test data from material suppliers can be leveraged.
Are cytotoxicity, sensitization, and irritation all required for wearable devices?
For devices with prolonged or permanent skin contact, all three are required by ISO 10993-1. Cytotoxicity is required for all skin-contact devices regardless of duration. Sensitization and irritation are required for contact exceeding 24 hours. For limited-contact devices (≤ 24 hours), sensitization and irritation are evaluated on a case-by-case basis, but most notified bodies will expect them to be addressed in the biological evaluation.
Can chemical characterization (ISO 10993-18) replace biological testing?
Chemical characterization can reduce the biological testing burden but cannot fully replace it. If chemical characterization and toxicological risk assessment demonstrate that all identified leachables are below toxicologically relevant thresholds, some biological endpoints may be waived per ISO 10993-1. However, cytotoxicity testing is almost always required regardless of chemical characterization results. EU notified bodies are increasingly accepting chemical characterization as the primary evidence for biological safety, but this requires a thorough, well-documented evaluation.
What is the difference between FDA and CE MDR biocompatibility requirements?
Both FDA and EU MDR require compliance with ISO 10993, but EU MDR places greater emphasis on chemical characterization (ISO 10993-18), requires a formal Biological Evaluation Plan and Report in the technical documentation, and prefers in vitro test methods (ISO 10993-23) over animal testing. FDA accepts the ISO 10993-1 endpoint matrix, strongly recommends chemical characterization for all devices, and provides specific guidance on biocompatibility for 510(k) submissions.
Planning biocompatibility testing for your wearable device? Our team works with ISO 10993-accredited laboratories and can provide material documentation, sample preparation, and regulatory guidance to streamline your submission. Contact us to discuss your testing requirements.